Nomura upgraded Raffles Medical Group to Buy from Neutral with an unchanged price target of S$1.60. The analyst sees the company benefiting from an increase in local and foreign patients in its Singapore hospitals.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>